{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T21:15:02Z","timestamp":1783458902974,"version":"3.55.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473897"],"award-info":[{"award-number":["82473897"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273905"],"award-info":[{"award-number":["82273905"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073828"],"award-info":[{"award-number":["82073828"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.neuropharm.2026.111009","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:32:55Z","timestamp":1778243575000},"page":"111009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Antidepressant-like activity of JZ-1201 in male rodents: a novel selective 5-HT\/NE reuptake inhibitor and 5-HT1A receptor partial agonist"],"prefix":"10.1016","volume":"298","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9471-6868","authenticated-orcid":false,"given":"Huan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengliang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.111009_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110210","article-title":"The 5-HT(1A) receptor as a serotonergic target for neuroprotection in cerebral ischemia","volume":"109","author":"Aguiar","year":"2021","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111009_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1756-6606-4-21","article-title":"Transcriptional dysregulation of 5-HT1A autoreceptors in mental illness","volume":"4","author":"Albert","year":"2011","journal-title":"Mol. Brain"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111009_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2012.09.006","article-title":"Serotonin receptors involved in antidepressant effects","volume":"137","author":"Artigas","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111009_bib4","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0165-6147(00)01682-5","article-title":"How does pindolol improve antidepressant action?","volume":"22","author":"Artigas","year":"2001","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111009_bib5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/pr.111.005108","article-title":"Brain-derived neurotrophic factor and neuropsychiatric disorders","volume":"64","author":"Autry","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2026.111009_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neulet.2017.08.019","article-title":"A standardization of the novelty-suppressed feeding test protocol in rats","volume":"658","author":"Blasco-Serra","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2026.111009_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2025.1591973","article-title":"Sex differences in anxiety and depression: insights from adult rodent models of chronic stress and neural plasticity","volume":"19","author":"Bowman","year":"2025","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111009_bib8","first-page":"5","article-title":"Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice","volume":"5","author":"Castagn\u00e9","year":"2010","journal-title":"Curr. Protoc. Pharmacol."},{"issue":"Pt B","key":"10.1016\/j.neuropharm.2026.111009_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.nbd.2016.07.010","article-title":"Brain-derived neurotrophic factor in mood disorders and antidepressant treatments","volume":"97","author":"Castren","year":"2017","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111009_bib10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.biopsych.2021.05.008","article-title":"Brain-derived neurotrophic factor signaling in depression and antidepressant action","volume":"90","author":"Castr\u00e9n","year":"2021","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111009_bib11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40263-013-0071-0","article-title":"Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research","volume":"27","author":"Celada","year":"2013","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111009_bib12","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/0269881115581093","article-title":"Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British association for psychopharmacology guidelines","volume":"29","author":"Cleare","year":"2015","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111009_bib13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41392-024-01738-y","article-title":"Major depressive disorder: hypothesis, mechanism, prevention and treatment","volume":"9","author":"Cui","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111009_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1755-5949.2008.00067.x","article-title":"A 5-HT1A receptor agonist\/serotonin transporter inhibitor for the treatment of affective disorders","volume":"15","author":"Dawson","year":"2009","journal-title":"CNS Neurosci. Ther."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111009_bib19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nm.4050","article-title":"Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants","volume":"22","author":"Duman","year":"2016","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111009_bib18","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0006-3223(00)00935-5","article-title":"Neuronal plasticity and survival in mood disorders","volume":"48","author":"Duman","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"6103","key":"10.1016\/j.neuropharm.2026.111009_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1126\/science.1222939","article-title":"Synaptic dysfunction in depression: potential therapeutic targets","volume":"338","author":"Duman","year":"2012","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111009_bib16","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111009_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tins.2011.11.004","article-title":"Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents","volume":"35","author":"Duman","year":"2012","journal-title":"Trends Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111009_bib20","first-page":"277","article-title":"[Antiserotonergic effect of antidepressives in L-5-HTP-induced head shaking behavior in the rat]","volume":"39","author":"Fischer","year":"1984","journal-title":"Pharmazie"},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111009_bib21","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/s41386-020-0705-0","article-title":"Medial PFC AMPA receptor and BDNF signaling are required for the rapid and sustained antidepressant-like effects of 5-HT(1A) receptor stimulation","volume":"45","author":"Fukumoto","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111009_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neubiorev.2019.04.002","article-title":"Depression in neurodegenerative diseases: common mechanisms and current treatment options","volume":"102","author":"Galts","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2026.111009_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108376","article-title":"Neuropharmacological and antidepressant-like effects of ZY-1408: a novel serotonin\/norepinephrine reuptake inhibitor and serotonin receptor 2C antagonist","volume":"182","author":"Gao","year":"2021","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111009_bib24","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/cns.13630","article-title":"GW117: a novel serotonin (5-HT(2C)) receptor antagonist and melatonin (MT(1)\/MT(2)) receptor agonist with potential antidepressant-like activity in rodents","volume":"27","author":"Gao","year":"2021","journal-title":"CNS Neurosci. Ther."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111009_bib25","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1002\/med.22049","article-title":"Advances in drug design and therapeutic potential of selective or multitarget 5-HT1A receptor ligands","volume":"44","author":"Giorgioni","year":"2024","journal-title":"Med. Res. Rev."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111009_bib27","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuropharm.2011.03.004","article-title":"5-HT(1A)-receptor over-expressing mice: genotype and sex dependent responses to antidepressants in the forced swim-test","volume":"61","author":"G\u00fcnther","year":"2011","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111009_bib26","doi-asserted-by":"crossref","first-page":"857","DOI":"10.4140\/TCP.n.2012.857","article-title":"Vilazodone hydrochloride, a combined SSRI and 5-HT1A receptor agonist for major depressive disorder","volume":"27","author":"Guay","year":"2012","journal-title":"Consult. Pharm."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111009_bib28","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/dneu.22592","article-title":"Differential effects of transient and sustained activation of BDNF-TrkB signaling","volume":"78","author":"Guo","year":"2018","journal-title":"Dev. Neurobiol."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111009_bib29","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.neulet.2009.11.019","article-title":"Possible association between the pituitary adenylate cyclase-activating polypeptide (PACAP) gene and major depressive disorder","volume":"468","author":"Hashimoto","year":"2010","journal-title":"Neurosci. Lett."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2026.111009_bib30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2005.01.018","article-title":"Neurochemical evaluation of the novel 5-HT1A receptor partial agonist\/serotonin reuptake inhibitor, vilazodone","volume":"510","author":"Hughes","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111009_bib31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bbi.2024.07.037","article-title":"Sex differences in the inflammation-depression link: a systematic review and meta-analysis","volume":"121","author":"Jarkas","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"7215","key":"10.1016\/j.neuropharm.2026.111009_bib32","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature07455","article-title":"The molecular neurobiology of depression","volume":"455","author":"Krishnan","year":"2008","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111009_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv115","article-title":"Leptin\/LepRb in the ventral tegmental area mediates anxiety-related behaviors","volume":"19","author":"Liu","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2026.111009_bib34","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6871089","article-title":"The role of neural plasticity in depression: from hippocampus to prefrontal cortex","volume":"2017","author":"Liu","year":"2017","journal-title":"Neural Plast."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111009_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0149-7634(94)90039-6","article-title":"Antidepressant-like behavioral effects of serotonin receptor agonists","volume":"18","author":"Lucki","year":"1994","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2026.111009_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.rcsop.2025.100644","article-title":"Impact of pharmaceutical care interventions on antidepressants adherence and clinical outcomes in depressed patients: a systematic review","volume":"20","author":"Marasine","year":"2025","journal-title":"Exploratory research in clinical and social pharmacy"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111009_bib37","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0022-3565(24)29479-9","article-title":"Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice","volume":"298","author":"Mayorga","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuropharm.2026.111009_bib38","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.77455","article-title":"BDNF\/TrkB signaling endosomes in axons coordinate CREB\/mTOR activation and protein synthesis in the cell body to induce dendritic growth in cortical neurons","volume":"12","author":"Moya-Alvarado","year":"2023","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111009_bib39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00423314","article-title":"Effects of amitriptyline and isocarboxazid on 5-hydroxytryptophan induced head twitches in mice","volume":"48","author":"Nakamura","year":"1976","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.111009_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107937","article-title":"Translating biased agonists from molecules to medications: serotonin 5-HT(1A) receptor functional selectivity for CNS disorders","volume":"229","author":"Newman-Tancredi","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"20","key":"10.1016\/j.neuropharm.2026.111009_bib41","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.2174\/138161210791792831","article-title":"Pharmacogenetic insights into depression and antidepressant response: does sex matter?","volume":"16","author":"Pitychoutis","year":"2010","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111009_bib42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0165-0327(02)00062-9","article-title":"Pindolol and the acceleration of the antidepressant response","volume":"75","author":"Plenge","year":"2003","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2026.111009_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2025.105937","article-title":"Sigma-1 receptor activation produces faster antidepressant-like effect through enhancement of hippocampal neuroplasticity: focus on sigma-1-5-HT1A heteroreceptor complex","volume":"184","author":"Ren","year":"2025","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111009_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105549","article-title":"Functional profiling of the G protein-coupled receptor C3aR1 reveals ligand-mediated biased agonism","volume":"300","author":"Rodriguez","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"5634","key":"10.1016\/j.neuropharm.2026.111009_bib45","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.1083328","article-title":"Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants","volume":"301","author":"Santarelli","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2026.111009_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1495598","article-title":"Pituitary adenylyl cyclase-activating polypeptide modulates the stress response: the involvement of different brain areas and microglia","volume":"15","author":"Singh","year":"2025","journal-title":"Front. Psychiatr."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111009_bib47","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s40263-023-01014-7","article-title":"The serotonin 1A (5-HT(1A)) receptor as a pharmacological target in depression","volume":"37","author":"Smith","year":"2023","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2026.111009_bib48","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jad.2023.08.106","article-title":"Major depressive disorder with suicidal ideation or behavior in Chinese population: a scoping review of current evidence on disease assessment, burden, treatment and risk factors","volume":"340","author":"Su","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"6618","key":"10.1016\/j.neuropharm.2026.111009_bib49","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1126\/science.abo3566","article-title":"Design of fast-onset antidepressant by dissociating SERT from nNOS in the DRN","volume":"378","author":"Sun","year":"2022","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111009_bib50","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1254\/jphs.12039FP","article-title":"Imipramine induces brain-derived neurotrophic factor mRNA expression in cultured astrocytes","volume":"120","author":"Takano","year":"2012","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111009_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/srep13573","article-title":"Involvement of normalized NMDA receptor and mTOR-related signaling in rapid antidepressant effects of Yueju and ketamine on chronically stressed mice","volume":"5","author":"Tang","year":"2015","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111009_bib52","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1038\/s41380-022-01520-y","article-title":"Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications","volume":"27","author":"Tartt","year":"2022","journal-title":"Mol Psychiatry"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111009_bib53","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s12264-024-01270-7","article-title":"Behavioral animal models and neural-circuit framework of depressive disorder","volume":"41","author":"Tian","year":"2025","journal-title":"Neurosci. Bull."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111009_bib54","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14598","article-title":"A novel NMDA receptor modulator: the antidepressant effect and mechanism of GW043","volume":"30","author":"Tiliwaerde","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111009_bib55","doi-asserted-by":"crossref","first-page":"7368","DOI":"10.1007\/s12035-019-1613-3","article-title":"S-Ketamine reverses hippocampal dendritic spine deficits in flinders sensitive line rats within 1 h of administration","volume":"56","author":"Treccani","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111009_bib56","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2021.12.003","article-title":"BDNF signaling in context: from synaptic regulation to psychiatric disorders","volume":"185","author":"Wang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2026.111009_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106903","article-title":"Synthesis and biological evaluation of novel 3-(5-substituted-1H-indol-3-yl)pyrrolidine-2,5-dione derivatives with a dual affinity for serotonin 5-HT(1A) receptor and SERT","volume":"141","author":"Wrobel","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"Pt 2","key":"10.1016\/j.neuropharm.2026.111009_bib58","article-title":"Chronic treatment of mixture of two iridoids proportional to prescriptional dose of Yueju improves hippocampal PACAP-related neuroinflammation and neuroplasticity signaling in the LPS-induced depression model","volume":"338","author":"Wu","year":"2025","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111009_bib59","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13041-017-0306-y","article-title":"The role of 5-HT receptors in depression","volume":"10","author":"Yohn","year":"2017","journal-title":"Mol. Brain"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111009_bib60","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/dneu.20765","article-title":"Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease","volume":"70","author":"Yoshii","year":"2010","journal-title":"Dev. Neurobiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111009_bib61","first-page":"49","article-title":"Hippocampal PACAP signaling activation triggers a rapid antidepressant response","volume":"11","author":"Zhang","year":"2024","journal-title":"Mil Med Res"}],"updated-by":[{"DOI":"10.1016\/j.neuropharm.2026.111039","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000}},{"DOI":"10.1016\/j.neuropharm.2026.111039","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000}}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826001826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826001826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:30:35Z","timestamp":1783456235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826001826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":61,"alternative-id":["S0028390826001826"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111009","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant-like activity of JZ-1201 in male rodents: a novel selective 5-HT\/NE reuptake inhibitor and 5-HT1A receptor partial agonist","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111009"}}